Peru halts Sinopharm coronavirus vaccine trials after volunteer develops neurological problems

Peru has temporarily suspended clinical trials of a Covid-19 vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.The National Institute of Health said on Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.“Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms…

Read the original article at South China Morning Post